Publisher
Springer Berlin Heidelberg
Reference52 articles.
1. Adamietz IA, Schöber C, Schulte RWM et al (1991) Palliative radiotherapy in plasma cell myeloma. Radiother Oncol 20:111–116
2. Alexanian R, Haut A, Khan AU et al (1969) Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. JAMA 208:1680–1685
3. Alexanian R, Dimopoulos MA, Delasalle K, Barlogie B (1992) Primary dexamethasone treatment of multiple myeloma. Blood 80:887–890
4. Alberts DS, Salmon SE (1975) Adriamycin (NSC-123127) in the treatment of alkylator-resistant multiple myeloma: a pilot study. Cancer Chemother Rep 59:345–350
5. Alsina M, Fonseca R, Wilson EF et al (2004) Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma. Blood 103:3271–3277